HIGHLIGHTS
- who: SUMOylation and colleagues from the Branch, National Institutes of Health (NINDS/NIH), National Institute of Neurological Disorders and, Bethesda, MD, USA Department of Clinical Neurosciences, University of Cambridge, UK have published the Article: SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke, in the Journal: (JOURNAL)
- what: The work in sought to explore the effects of the recruitment and optimization of a global neuroprotective modality (i.e. SUMOylation) on the efficacy of NSC cell-based therapy. Critically, the authors demonstrate that Sox2 - a key transcription factor essential for maintaining self . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.